133 related articles for article (PubMed ID: 19175716)
1. Adverse effects of concurrent carboplatin chemotherapy and radiation therapy in dogs.
Hume KR; Johnson JL; Williams LE
J Vet Intern Med; 2009; 23(1):24-30. PubMed ID: 19175716
[TBL] [Abstract][Full Text] [Related]
2. Concurrent 5-fluorouracil and carboplatin for the treatment of canine carcinomas.
Menard K; Flesner BK; Glahn A; Boudreaux B; Bryan JN
Vet Comp Oncol; 2018 Dec; 16(4):590-595. PubMed ID: 30043425
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin-induced myelosuppression as related to body weight in dogs.
Coffee C; Roush JK; Higginbotham ML
Vet Comp Oncol; 2020 Dec; 18(4):804-810. PubMed ID: 32452107
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).
Gillem J; Giuffrida M; Krick E
Vet Comp Oncol; 2017 Jun; 15(2):400-410. PubMed ID: 26463827
[TBL] [Abstract][Full Text] [Related]
5. Phase I clinical evaluation of carboplatin in tumor-bearing cats: a Veterinary Cooperative Oncology Group study.
Kisseberth WC; Vail DM; Yaissle J; Jeglum KA; Couto CG; Ward H; Khanna C; Obradovich JE
J Vet Intern Med; 2008; 22(1):83-8. PubMed ID: 18289293
[TBL] [Abstract][Full Text] [Related]
6. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
Heading KL; Brockley LK; Bennett PF
Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164
[TBL] [Abstract][Full Text] [Related]
7. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder.
Chun R; Knapp DW; Widmer WR; DeNicola DB; Glickman NW; Kuczek T; Degortari A; Han CM
J Vet Intern Med; 1997; 11(5):279-83. PubMed ID: 9348494
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a manual technique for detection of neutropenia and thrombocytopenia in dogs receiving chemotherapy.
Wyatt KM; Wyatt GL
J Am Vet Med Assoc; 2002 Jun; 220(12):1805-6. PubMed ID: 12092952
[TBL] [Abstract][Full Text] [Related]
9. Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.
Wouda RM; Hocker SE; Higginbotham ML
Vet Comp Oncol; 2018 Mar; 16(1):E52-E60. PubMed ID: 28799187
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer.
Dubay RA; Rose PG; O'Malley DM; Shalodi AD; Ludin A; Selim MA
Gynecol Oncol; 2004 Jul; 94(1):121-4. PubMed ID: 15262129
[TBL] [Abstract][Full Text] [Related]
11. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989-2000).
Rassnick KM; Ruslander DM; Cotter SM; Al-Sarraf R; Bruyette DS; Gamblin RM; Meleo KA; Moore AS
J Am Vet Med Assoc; 2001 May; 218(9):1444-8. PubMed ID: 11345308
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006-2010).
Simcock JO; Withers SS; Prpich CY; Kuntz CA; Rutland BE
J Am Vet Med Assoc; 2012 Sep; 241(5):608-14. PubMed ID: 22916858
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of metronomic administration of lomustine in dogs with cancer.
Tripp CD; Fidel J; Anderson CL; Patrick M; Pratt C; Sellon R; Bryan JN
J Vet Intern Med; 2011; 25(2):278-84. PubMed ID: 21314727
[TBL] [Abstract][Full Text] [Related]
14. Hemorrhagic cystitis in a dog receiving carboplatin.
MacDonald V; Dickinson R
J Am Anim Hosp Assoc; 2014; 50(1):67-70. PubMed ID: 24216493
[TBL] [Abstract][Full Text] [Related]
15. A phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma.
Dunphy FR; Boyd JH; Kim HJ; Dunphy CH; Harrison BR; Dunleavy TL; Rodriguez JJ; McDonough EM; Minster JR; Hilton JG
Cancer; 1997 May; 79(10):2016-23. PubMed ID: 9149030
[TBL] [Abstract][Full Text] [Related]
16. Effects of lithium carbonate on carboplatin-induced thrombocytopenia in dogs.
Leclerc A; Abrams-Ogg AC; Kruth SA; Bienzle D
Am J Vet Res; 2010 May; 71(5):555-63. PubMed ID: 20433382
[TBL] [Abstract][Full Text] [Related]
17. Combined gemcitabine and carboplatin therapy for carcinomas in dogs.
Dominguez PA; Dervisis NG; Cadile CD; Sarbu L; Kitchell BE
J Vet Intern Med; 2009; 23(1):130-7. PubMed ID: 19175731
[TBL] [Abstract][Full Text] [Related]
18. Case-control study to evaluate risk factors for the development of sepsis (neutropenia and fever) in dogs receiving chemotherapy.
Sorenmo KU; Harwood LP; King LG; Drobatz KJ
J Am Vet Med Assoc; 2010 Mar; 236(6):650-6. PubMed ID: 20225976
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the risks of chemotherapy in dogs with thrombocytopenia.
Finlay J; Wyatt K; Black M
Vet Comp Oncol; 2017 Mar; 15(1):151-162. PubMed ID: 25864417
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients.
Katanyoo K; Tangjitgamol S; Chongthanakorn M; Tantivatana T; Manusirivithaya S; Rongsriyam K; Cholpaisal A
Gynecol Oncol; 2011 Dec; 123(3):571-6. PubMed ID: 21955483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]